Hossein Pakdaman

812 total citations
44 papers, 585 citations indexed

About

Hossein Pakdaman is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Hossein Pakdaman has authored 44 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 13 papers in Psychiatry and Mental health. Recurrent topics in Hossein Pakdaman's work include Multiple Sclerosis Research Studies (13 papers), Alzheimer's disease research and treatments (5 papers) and Epilepsy research and treatment (5 papers). Hossein Pakdaman is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Alzheimer's disease research and treatments (5 papers) and Epilepsy research and treatment (5 papers). Hossein Pakdaman collaborates with scholars based in Iran, United States and Canada. Hossein Pakdaman's co-authors include Leila Simani, Mahtab Ramezani, Mohammad Ali Sahraian, Mastooreh Sagharichi, Ilad Alavi Darazam, Mohammad Amin Aalipour, Fatemeh Ghorbani, Omidvar Rezaei, Koorosh Shahpasand and Ali Amini Harandi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Scientific Reports.

In The Last Decade

Hossein Pakdaman

42 papers receiving 569 citations

Peers

Countries citing papers authored by Hossein Pakdaman

Since Specialization

Citations

This map shows the geographic impact of Hossein Pakdaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Pakdaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Pakdaman more than expected).

Fields of papers citing papers by Hossein Pakdaman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossein Pakdaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Pakdaman. The network helps show where Hossein Pakdaman may publish in the future.

Co-authorship network of co-authors of Hossein Pakdaman

This figure shows the co-authorship network connecting the top 25 collaborators of Hossein Pakdaman. A scholar is included among the top collaborators of Hossein Pakdaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hossein Pakdaman. Hossein Pakdaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of depression after Parkinson’s disease, stroke, multiple sclerosis, and migraine in an Iranian population and assess psychometric characteristics of three prevalent depression questionnaires 2024 ·IBRO Neuroscience Reports ·Mehri Salari, Hossein Pakdaman, Masoud Etemadifar, (unknown), (unknown), (unknown), (unknown)	1
2	MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study 2023 ·Medicine ·Hossein Pakdaman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ali Amini Harandi	3
3	P38 initiates degeneration of midbrain GABAergic and glutamatergic neurons in diabetes models 2022 ·European Journal of Neuroscience ·(unknown), Mehdi Totonchi, (unknown), Hossein Baharvand, Hossein Pakdaman, Ensiyeh Hajizadeh‐Saffar, Seyed Ahmad Mousavi, (unknown), Hamed Al Sinawi, Quan Li, Jin‐San Zhang, Yaser Tahamtani, Koorosh Shahpasand	1
4	Vascular Endothelial Growth Factor as a Predictive and Prognostic Biomarker for Multiple Sclerosis 2022 ·NeuroImmunoModulation ·Ali Amini Harandi, (unknown), (unknown), (unknown), Hossein Pakdaman, Mohammad Ali Sahraian, (unknown), (unknown), (unknown), Seyed Hossein Ardehali	9
5	Developing a novel prediction model in opioid overdose using machine learning; a pilot analytical study 2022 ·Health Science Reports ·(unknown), (unknown), (unknown), (unknown), Hossein Hassanian‐Moghaddam, Roman Bauer, Nasim Zamani, Hossein Pakdaman, (unknown)	1
6	Tau nuclear translocation is a leading step in tau pathology process through P53 stabilization and nucleolar dispersion 2022 ·Journal of Neuroscience Research ·(unknown), Shahin Ahmadian, (unknown), Hossein Pakdaman, (unknown), (unknown), Koorosh Shahpasand	11
7	Does vitamin D administration play a role in outcome of patients with acute ischemic stroke? A randomized controlled trial 2021 ·PubMed ·Omidvar Rezaei, Mahtab Ramezani, Mehrdad Roozbeh, (unknown), Mohammadreza Hajiesmaeili, Hossein Pakdaman, Leila Simani	4
8	Epilepsy lifetime prevalence in Iran: a large population- based national survey 2021 ·Scientific Reports ·Hossein Pakdaman, Ali Amini Harandi, (unknown), Farshid Alaeddini, (unknown), (unknown), Taher Doroudi, Pirhossein Kolivand, (unknown), Hadi Kazemi	9
9	The Neurological Manifestations as an Onset Symptom of Antiphospholipid Syndrome: Report of Two Cases 2019 ·(unknown), (unknown), Hossein Pakdaman, (unknown), Ayşe Altıntaş, Ommega Internationals	0
10	A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis 2018 ·Neurological Sciences ·Hossein Pakdaman, Mehdi Abbasi, (unknown), Farzad Ashrafi, (unknown), Ali Amini Harandi	6
11	Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study 2018 ·Dementia and Geriatric Cognitive Disorders Extra ·Hossein Pakdaman, (unknown), Mehdi Abbasi, (unknown), (unknown), Farzad Ashrafi, (unknown), Ali Amini Harandi	4
12	MLC601 in vascular dementia: an efficacy and safety pilot study 2017 ·Neuropsychiatric Disease and Treatment ·Hossein Pakdaman, Ali Amini Harandi, (unknown), Mehdi Abbasi, Majid Ghaffarpour, Farzad Ashrafi, (unknown), (unknown)	4
13	Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran 2016 ·Neurological Sciences ·Hossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, (unknown), (unknown), (unknown), (unknown), Omidvar Rezaei, (unknown), Guive Sharifi, (unknown), (unknown), Farzad Ashrafi, (unknown), (unknown), Mehran Arab Ahmadi, Behdad Behnam	20
14	Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial 2015 ·SHILAP Revista de lepidopterología ·Hossein Pakdaman, Ali Amini Harandi, (unknown), (unknown), (unknown), (unknown), (unknown), Farzad Ashrafi, (unknown), (unknown), (unknown)	15
15	Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region 2013 ·International Journal of Neuroscience ·(unknown), (unknown), Saeed Bohlega, Maurice Dahdaleh, Abdulkader Daif, Dirk Deleu, (unknown), (unknown), Mark S. Freedman, Michael Gwilt, (unknown), Jihad Inshasi, Mohammed Aljumah, Ahmad Khalifa, Hossein Pakdaman, Miklós Szólics, Bassem Yamout, Mohammad Ali Sahraian, Magd Zakaria	11
16	Barking seizure: Acute episodes of barking in a 75-year-old previously healthy man 2012 ·Seizure ·Ali Amini Harandi, (unknown), Marjan Asadollahi, Farzad Fatehi, Hossein Pakdaman, (unknown)	2
17	Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010 2012 ·Neurological Sciences ·(unknown), Seyed‐Mohammad Fereshtehnejad, Navid Mohammadi, (unknown), (unknown), (unknown), Hossein Pakdaman	28
18	Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients 2010 ·Toxicology Mechanisms and Methods ·(unknown), Mohammad Hossein Ghahremani, Reza Ahmadkhaniha, Ali Mandegary, (unknown), Mohammad Abdollahı, Shahin Shadnia, Hossein Pakdaman, Abbas Kebriaeezadeh	27
19	Magnetic Resonance Imaging Abnormalities in Multiple Sclerosis: A Review 2007 ·Iranian Journal of Radiology ·(unknown), (unknown), (unknown), Ernst‐Wilhelm Radue, Hossein Pakdaman	3
20	Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event 2007 ·Acta Neurologica Scandinavica ·Hossein Pakdaman, Mohammad Ali Sahraian, (unknown), (unknown), (unknown), (unknown), (unknown), Afsaneh Shirani	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact